Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001193125-26-104162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-10 | LMAT | LeBlanc Dorian Paul | CFO | M - OptEx | $0.00 | +2 | 2,400 | +0.1% | $0 |
| D | 2026-03-12 | 2026-03-10 | LMAT | LeBlanc Dorian Paul | CFO | F - Tax | $109.20 | -96 | 2,302 | -4% | -$10.5K |
| D | 2026-03-12 | 2026-03-10 | LMAT | LeBlanc Dorian Paul | CFO | M - OptEx | $0.00 | -2 | 9.33 | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | M | A | 2 | $0.00 | 2,400 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-03-10 | F | D | 96 | $109.20 | 2,302 | D | — | — | (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on March 10, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 3 | Derivative | Dividend Equivalent Rights | 2026-03-10 | M | D | 2 | $0.00 | 9.33 | D | — · — to — | 2 Common Stock | (F3) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on March 10, 2025. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |